Filing metadata

Accession number
0001104659-23-002821
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Jan 10, 2023
Reporting period
Jan 06, 2023
Description
Insider transaction

Explore SEC Filings Hub